(Q43089505)

13 November 2017

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. (English)

1 reference

13 November 2017

6

A Tefferi

1 reference

13 November 2017

A Pardanani

1

1 reference

13 November 2017

T L Lasho

2

1 reference

13 November 2017

C M Finke

3

1 reference

13 November 2017

M Mai

4

1 reference

13 November 2017

R F McClure

5

1 reference

13 November 2017

22 April 2010

1 reference

13 November 2017

1 reference

13 November 2017

24

1 reference

13 November 2017

1146-1151

1 reference

13 November 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.77

13 November 2017

0 references

cites work

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Absence of IDH2 codon 172 mutation in common human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Taxing sugar-sweetened beverages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2010.77

1 reference

Dimensions Publication ID

13 November 2017

0 references

1 reference